Picture of Viatris logo

VTRS Viatris Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Annual income statement for Viatris, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue11,50111,94617,88616,26315,427
Cost of Revenue
Gross Profit4,5524,5426,5607,0336,732
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses10,79612,17417,92814,65214,685
Operating Profit705-228-421,611742
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes154-721-6642,813203
Provision for Income Taxes
Net Income After Taxes16.8-670-1,2692,07954.7
Net Income Before Extraordinary Items
Net Income16.8-670-1,2692,07954.7
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income16.8-670-1,2692,07954.7
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS1.180.7130.0542.420.537
Dividends per Share